ResearchMoz

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

Transparency Market Research
Published Date » 2012-10-08
No. Of Pages » 130
   
 This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives.  
   
  This report highlights...
TABLE OF CONTENTS

CHAPTER 1 PREFACE
1.1 KEY POINTS COVERED
1.2 REPORT DESCRIPTION
1.3 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY AND MARKET OVERVIEW

CHAPTER 3 INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS
3.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017
3.1.1 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET, 2010 V/S 2017
3.1.2 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017
GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017
3.2 POPULATION GROWTH TREND
3.2.1 GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP
3.2.2 INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY GEOGRAPHY
3.3 CAUSES OF INFERTILITY
3.4 MARKET DYNAMICS
3.4.1 DRIVERS
3.4.1.1 Rising number of infertile people
3.4.1.2 Increasing worldwide obesity
3.4.1.3 Rising disposable incomes of the consumers
3.4.1.4 Lifestyle hazards such as rising number of smokers, stress and pollution
3.4.1.5 Adoption of babies by homosexual couples
3.4.1.6 Availability of government support for infertility abatement procedures
3.4.2 INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS
3.4.3 RESTRAINTS
3.4.3.1 Limited insurance covers
3.4.3.2 Religious bans on artificial insemination procedures especially the Islamic bans
3.4.3.3 Risk of repeat procedures
3.4.3.4 Traditional infertility treatments such as the Chinese infertility treatments
3.4.3.5 Ban on artificial reproduction procedures in European countries especially Turkey, Germany, Italy and France
3.4.3.6 Patent expiration of infertility drugs
3.4.4 INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
3.4.5 OPPORTUNITY
3.4.5.1 Technological advancements in the Asia Pacific region and the developmental activities in the region
3.4.5.2 Medical tourism initiatives in the developing countries
3.4.5.3 Need for more ART cycles
3.1 MARKET SHARE ANALYSIS, 2011
3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET
3.2.1 BARGAINING POWER OF SUPPLIERS
3.2.1 BARGAINING POWER OF BUYERS
3.2.2 THREAT OF NEW ENTRANTS
3.2.3 THREAT OF SUBSTITUTES
3.2.4 COMPETITIVE RIVALRY

CHAPTER 4 INFERTILITY DRUGS AND DEVICES MARKET SEGMENTATION
4.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES
4.1.1 FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.1.1 Global Infertility drugs and devices market by Endometriosis female infertility types
4.1.1.2 Global Infertility drugs and devices market by Ovarian disorder female infertility types
4.1.1.3 Global Infertility drugs and devices market by Uterine disorder female infertility types
4.1.1.4 Global Infertility drugs and devices market by Tubal disorder female infertility types
4.1.1.5 Global Infertility drugs and devices market by Hormonal disorder female infertility types
4.1.2 MALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.2.1 Global Infertility drugs and devices market by Azoospermia male infertility types
4.1.2.2 Global Infertility drugs and devices market by Varicocele male infertility types
4.1.2.3 Global Infertility drugs and devices market by Ejaculation Disorder male infertility types
4.1.2.4 Global Infertility drugs and devices market by Erectile Dysfunction male infertility types
4.2 INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY
4.2.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION
4.2.2 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED REPRODUCTIVE TECHNOLOGIES (USD THOUSAND) 
4.2.3 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO FERTILIZATION (USD THOUSAND) 
4.2.4 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD THOUSAND) 57

CHAPTER 5 REGION-WISE ANALYSIS
5.1 INFERTILITY DRUGS AND DEVICES MARKET BY REGION
5.1.1 EUROPE INFERTILITY DRUGS AND DEVICES MARKET
5.1.1.1 U.K
5.1.1.2 France
5.1.1.3 Germany
5.1.1.4 Italy
5.1.1.5 Spain
5.1.2 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3.1 U.S
5.1.3.2 CANADA
5.1.3.3 MEXICO
5.1.4 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5.1 Japan
5.1.5.2 India
5.1.5.3 China
5.1.6 ROW INFERTILITY DRUGS AND DEVICES MARKET
5.1.7 ROW INFERTILITY DRUGS AND DEVICES MARKET
  5.1.7.1 Brazil’s Infertility drugs and devices market

CHAPTER 6 COMPANY PROFILES
6.1 JOHNSON & JOHNSON
6.1.1 COMPANY OVERVIEW
6.1.2 FINANCIAL OVERVIEW
6.1.3 BUSINESS STRATEGIES
6.1.4 RECENT DEVELOPMENTS
6.2 MERCK
6.2.1 COMPANY OVERVIEW
6.2.2 FINANCIAL OVERVIEW
6.2.3 BUSINESS STRATEGIES
6.2.4 PRODUCT PORTFOLIO
6.2.5 RECENT DEVELOPMENT
6.3 TEVA PHARMACEUTICALS
6.3.1 COMPANY OVERVIEW
6.3.2 FINANCIAL OVERVIEW
6.3.3 BUSINESS STRATEGIES
6.3.4 PRODUCT PORTFOLIO
6.3.5 RECENT DEVELOPMENTS
6.4 ORIGIO
6.4.1 COMPANY OVERVIEW
6.4.2 FINANCIAL OVERVIEW
6.4.3 BUSINESS STRATEGIES
6.4.4 PRODUCT PORTFOLIO
6.4.5 RECENT DEVELOPMENTS
6.5 BAYER
6.5.1 COMPANY OVERVIEW
6.5.2 FINANCIAL OVERVIEW
6.5.3 BUSINESS STRATEGIES
6.5.4 PRODUCT PORTFOLIO
6.5.5 RECENT DEVELOPMENT

List of Tables

LIST OF TABLES

TABLE 1 IMPACT ANALYSIS OF DRIVERS
TABLE 2 IMPACT ANALYSIS OF RESTRAINTS
TABLE 3 GLOBAL FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 4 GLOBAL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 5 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 6 U.K  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 7 U.K POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 8 U.K MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 9 U.K FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 10 U.K INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 11 U.K INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 12 FRANCE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 13 FRANCE POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 14 FRANCE MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 15 FRANCE FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 16 FRANCE INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 17 FRANCE INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 18 GERMANY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 19 GERMANY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 20 GERMANY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 21 GERMANY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 22 GERMANY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND 
TABLE 23 GERMANY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 24 ITALY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 25 ITALY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 26 ITALY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 27 ITALY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 28 ITALY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 29 ITALY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 30 SPAIN INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 31 SPAIN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 32 SPAIN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 33 SPAIN FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 34 SPAIN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 35 SPAIN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 36 U.S INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 37 U.S POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 38 U.S MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 39 U.S MALE INFERTILITY POPULATION TREATED, 2010 - 2017 (THOUSAND) 
TABLE 40 U.S FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 41 U.S INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 42 U.S INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 43 CANADA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 44 CANADA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 45 CANADA MALE INFERTILITY POPULATION PREVALENCE 2010 - 2017 (THOUSAND) 
TABLE 46 CANADA FEMALE INFERTILITY POPULATION PREVALENCE, 2010 – 2017 (THOUSAND) 
TABLE 47 CANADA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 48 CANADA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 49 MEXICO INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 50 MEXICO POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 51 MEXICO MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 52 MEXICO FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 53 MEXICO INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 54 MEXICO INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 55 JAPAN  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 56 JAPAN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 57 JAPAN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 58 JAPAN FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (MILLION) 
TABLE 59 JAPAN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 60 JAPAN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD MILLION) 
TABLE 61 INDIA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 62 INDIA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 63 INDIA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND
TABLE 64 INDIA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 65 INDIA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 66 INDIA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 67 CHINA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 68 CHINA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 69 CHINA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 70 CHINA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 71 CHINA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 72 CHINA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 73 ROW  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 74 ROW FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 75 ROW INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 76 BRAZIL  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 77 BRAZIL POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 78 BRAZIL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 79 BRAZIL FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 80 BRAZIL INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 81 BRAZIL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

List of Figures

LIST OF FIGURES

FIG. 1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 2 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET SHARE, 2010 VS 2017 
FIG. 3 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 4 GLOBAL POPULATION TREND, MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 5 GLOBAL FERTILE MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 6 GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 7 MARKET ATTRACTIVENESS - INFERTILITY DRUGS AND DEVICES MARKET BY GEOGRAPHY 
FIG. 8 CAUSES OF INFERTILITY 
FIG. 9 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET 
FIG. 10 COMPARITIVE ANALYSIS OF INFERTILITY DRUGS AND DEVICES MARKET SHARE BY GEOGRAPHY, 2010 AND 2017 (%) 
FIG. 11 EUROPE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 12 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 13 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 14 DECLINING FERTILITY RATE IN JAPAN, 2007 - 2011 
FIG. 15 ROW INFERTILITY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 16 JOHNSON & JOHNSON’S ANNUAL SALES, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 – 2010 (%) 
FIG. 17 MERCK’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 18 TEVA PHARMACEUTICAL’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 19 ORIGIO’S ANNUAL REVENUE, 2010 – 2011 (USD MILLION) 
FIG. 20 BAYER’S ANNUAL SALES, 2010 – 2011 (USD MILLION) 

Upcoming Reports:

Greece: market of fresh and chilled lamb and sheep meat
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fresh and chilled lamb and sheep meat market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fresh and chilled lamb and sheep meat market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same...
Bioinformatics in IVD Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Research efforts in last two decades have provided us huge amount of genomic information for almost each and every form of life. Bioinformatics is a multidisciplinary research field that combines computer science, biology, statistics and mathematics for the management of biological information. The software and applications used in bioinformatics is used to gather, analyze, store and integrate genetic and biological information which can later be applied to gene based drug developments. Computer diagnostics offers wide opportunities to clinicians and pathologists in detecting...
Intra Abdominal Infection Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Intra abdominal infections are a group of diseases of abdomen and are one of the most common causes of mortalities across the globe. These include peritonitis, intra abdominal abscess, diverticulitis, appendicitis, food poisoning and pelvic inflammatory disease. Post surgical infections are a major cause of intra abdominal infections. The infections can also occur due to inflammatory bowel disease, ruptured appendix, and intestinal infection. Symptoms may vary depending on the anatomical location of infection. Common symptoms include abdominal pain, chills, diarrhea, nausea, lack of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Speculation on Merger Raises the Stocks in China
Apr 27, 2015  
The stocks of China rallied up too much in three months among the speculation, which the government has been considering about merging the state-owned enterprises and taking some more steps that will support the economic growth. The Economic Information Daily informed that China Petroleum & Chemical Corp., Cosco Shipping Co., Baoshan Iron & Steel Co., and PetroChina Co., all...
Government Departments Missing Targets Set for Reducing Energy Consumption
Apr 27, 2015  
A new report provided by the SEAI (Sustainable Energy Authority of Ireland), which has been seen by the Irish Independent, presents that in 2013 the energy use has gone down by 14% in the public sector. However, EU and a Government have been focusing to reduce the consumption by about 33% by the end of 2020. This target has been curbed by a lack of progress in some of the prominent sectors....
Mysterious Dark Energy Search to be Done by Spy Telescopes
Apr 27, 2015  
NASA has been making some plans to use the two spy telescopes for the search of the mysterious dark-energy, which makes up around 68% of the universe. As per a senior official who is involved in this project informed that the U.S. space agency is planning to request for funds in the budget of next year's which will eventually start with using of these mentioned telescopes it has...
GM Food will not be Served Anymore by Chipotle
Apr 27, 2015  
Chipotle Mexican Grill which is a first of a major restaurant chain recently announced that it will start serving food which is free from genetically engineered stuff The founder Steve Ells who is the co chief executive of Chipotle, said this is another step towards their vision wherein they are changing the way people conceive and east fast food. Steve Ells further stated that just...
Organic Farmers Might Face Stringent Regulations
Apr 27, 2015  
The attraction of organic farming is a huge one; however, being an organic farmer is not as simple as looking at ideal farming landscape. The process of setting up and maintain an organic farm is expensive and the profits are minimal. In spite of the challenges, going organic in the transition time also adds to the costs, longer maturing time and even more farmers are signing up for...